Biosimilars are on track to reduce drug costs by $100 billion—but not everyone is on board. The Inflation Reduction Act has provisions that encourage their uptake. Get the details from PRECISIONvalue expert Amy Martin in this free brief (part 1 of 5).
The March Events Calendar is here! Stay up to date with all of the upcoming Precision conferences, on-demand events and recent thought leadership!
To be prepared for the next pandemic, we must consider what went wrong with the COVID-19 pandemic and what went right. From telemedicine services to licensure requirements, what does the health care community still need to do to prepare? Precision's Maureen Hennessey and Cynthia Miller discuss what infection prevention and control personnel need to know to prepare for future epidemics and pandemics. Installment 3 of 3.
In this 1 hour live webinar, Precision experts Thad Nowakowski, Tim Van Aken, and Maureen Hennessey discuss the role that Social Determinants of Health plays in contributing to care gaps, current or proposed quality measures to support health equity, and how the top EHR vendors are enabling end user’s efforts to both capture SDOH variables, and act upon them to close care gaps.
The media regularly covers the number of cases in the triple epidemic or “tripledemic” of influenza, COVID-19, and respiratory syncytial virus. Precision's Maureen Hennessey and Cynthia Miller argue the media should cover more expansive topics beyond the number of cases, and explain why advocacy groups are needed to assist patients dealing with COVID-19, long COVID, and the aftermath.
The “Triple Epidemic” seems to have peaked, but what is it, and what should every industry, health system, and other companies do to mitigate the damage the triple epidemic continues to cause? What should these institutions do to prevent another one? Did vaccine misinformation lead to the current triple epidemic? Did nurse burnout?Infection Control Today® (ICT®) spoke with Precision's Maureen Hennessey and Cynthia Miller for answers to these questions. Installment 1 of 3.
October 2022 heralded another crisis for hospitals and physicians: the tripledemic. It likely won't be the last season for a potential infectious disease calamity, so every healthcare stakeholder must play a role in mitigating the damage. However, issues such as staffing, vaccine fatigue, misinformation, and operational challenges may inhibit successful interventions. Precision's Maureen Hennessey and Cynthia Miller argue for the need to create a wholistic pandemic strategy that align's with the Quintuple Aim and supports the five aims: care-team well being, better patient care, healthier people, affordability, and health equity.
Frederick, MD – January 24, 2023 Precision for Medicine, the first global, precision medicine clinical research services organization, today announced the strategic acquisition of SolveBio by QuartzBio.
HEOR data can help to close knowledge gaps and uncertainties that payers may possess when making decisions involving access and reimbursement. Precision's Jacquelyn Chou, Alexandria Portelli and Andrew Cournoyer discuss important steps in prelaunch HEOR planning to support a successful market launch.
BETHESDA, MD (January 26, 2023) Precision Value & Health (PVH), today announces that Doug Fulling has joined as President. As the industry leader in delivering complementary, integrated and specialized capabilities across the commercialization continuum, Doug will be accountable for the overall strategy, organizational leadership, financial performance, and next-level growth of this market-leading commercial enterprise. Learn how an integrated data-driven approach can set realistic goals and de-risk your launch.
The Precision Value & Health family of brands is now Precision AQ
Precision AQ helps life sciences companies navigate the complexities of commercialization across a product’s lifecycle. Our team is comprised of experts, advisors, and creators working to ensure patients have access to life-changing medicines.
Our global offerings include:
Our name, which stands for Precision Access Quotient, reflects our approach to removing barriers – fusing together science (IQ, or Intelligence Quotient) and empathy (EQ, or Emotional Quotient). The result is “AQ: Access Quotient”, a critical ingredient in navigating the therapy-to-patient journey informed by data-driven analytics and insights.
To find out more about our global services and our unified mission, empowering access to life-changing medicines for all, visit: Precision AQ
